Multicenter International Prospective Registry to Identify Major Cardiovascular Events Associated With the Occurrence of Atrial Fibrillation in Active Cancer Patients

What this Trial Is About

Researchers are studying atrial fibrillation, a common heart rhythm problem, in adults who have active cancer. This study aims to better understand the occurrence and consequences of major cardiovascular events in these patients, which are not well covered by current cancer and heart disease guidelines. The study is an international, multicenter, prospective registry focusing on adults with cancer and atrial fibrillation. Adult patients with active cancer who experience atrial fibrillation are included in this observational study. Active cancer is defined as cancer diagnosed within the past 6 months, recurrent locally advanced or metastatic cancer, or patients receiving anticancer treatment currently or within 6 months before enrollment. Both new onset and recurring atrial fibrillation after cancer diagnosis are considered. Patients are followed for 1 year to track cardiovascular events and death. Participants will be monitored for major cardiovascular events and overall survival for one year from inclusion in the registry. Researchers will describe the patient population, atrial fibrillation management, and identify risk factors associated with cardiovascular events, mortality, and bleeding during this period. The study involves collecting patient information without changing their usual care, allowing close observation of the health outcomes related to atrial fibrillation in cancer patients.

Atrial Fibrillation in Active Cancer Patients